Can pain and function be distinguished in the Oxford Hip Score in a meaningful way? : an exploratory and confirmatory factor analysis.
Harris KK. et al, (2014), Bone Joint Res, 3, 305 - 309
CAPTURE THE FRACTURE: A WORLDWIDE INITIATIVE FOR THE SECONDARY PREVENTION OF OSTEOPOROTIC FRACTURE
Javaid MK. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, 572 - 572
DRUGS DON'T WORK IN PATIENTS WHO DON'T TAKE THEM .... PROPERLY
Fairclough V. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S703 - S704
EFFECTIVE SECONDARY FRACTURE PREVENTION: A GLOBAL BENCHMARKING OF CLINICAL QUALITY USING THE IOF BEST PRACTICE FRAMEWORK TOO
Javaid MK. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S691 - S691
FRACTURE LIAISON SERVICE DATABASE-EXPERIENCES OF USING A NATIONAL CLINICAL AUDIT TO MEASURE SECONDARY PREVENTION
Boulton C. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S675 - S676
OUTCOMES OF ONE YEAR FOLLOW UP POST ZOLEDRONATE THERAPY FOR OSTEOPOROSIS: AUTOMATIC PAUSE OR RESTART TREATMENT?
Patel MV. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S697 - S697
Pain and the PAG: learning from painful mistakes.
Eippert F. and Tracey I., (2014), Nat Neurosci, 17, 1438 - 1439
PARTICIPANTS IN THE ALENDRONATE PIVOTAL TRIAL COMPARED TO PRIMARY CARE 'REAL LIFE' DRUG USERS: A POPULATION-BASED COHORT STUDY
Prieto-Alhambra D. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S678 - S679
PATIENT SATISFACTION IN A NEWLY ESTABLISHED FRACTURE PREVENTION SERVICE
Morgan T. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S718 - S718
PREDICTORS OF SECOND FRACTURE WHILE ON TREATMENT WITH ORAL BISPHOSPHONATES: A MULTINATIONAL COHORT STUDY
Hawley S. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S670 - S671
Protocol for the Femoroacetabular Impingement Trial (FAIT): a multi-centre randomised controlled trial comparing surgical and non-surgical management of femoroacetabular impingement.
Palmer AJR. et al, (2014), Bone Joint Res, 3, 321 - 327
REPORTING AND FOLLOW-UP OF VERTEBRAL FRACTURES SEEN ON IMAGING; CAN RADIOLOGISTS HELP REDUCE THE NUMBER OF HIP FRACTURES?
Jewell PD. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S674 - S674
THE CARE HOME DIVIDE? A MISSED OPPORTUNITY FOR SECONDARY FRACTURE PREVENTION
Rance K. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S703 - S703
The role of FoxP3+regulatory T cells in psoriasiform skin disease
Adelmann K. et al, (2014), EXPERIMENTAL DERMATOLOGY, 23, 8 - 8
USING HOSPITAL EPISODE STATISTICS (HES) TO ESTIMATE THE FREQUENCY OF FRAGILITY FRACTURES
Neuburger J. et al, (2014), OSTEOPOROSIS INTERNATIONAL, 25, S681 - S682
Variation and genetic control of gene expression in primary immunocytes across inbred mouse strains.
Mostafavi S. et al, (2014), J Immunol, 193, 4485 - 4496
World Endometriosis Research Foundation Endometriosis Phenome and Biobanking Harmonization Project: II. Clinical and covariate phenotype data collection in endometriosis research.
Vitonis AF. et al, (2014), Fertil Steril, 102, 1223 - 1232
Splenic TFH expansion participates in B-cell differentiation and antiplatelet-antibody production during immune thrombocytopenia.
Audia S. et al, (2014), Blood, 124, 2858 - 2866
Nonclassical Ly6C(-) monocytes drive the development of inflammatory arthritis in mice.
Misharin AV. et al, (2014), Cell Rep, 9, 591 - 604